Cardinal Health

... Masimo 1819 MNC-I Spo2 Adaptor Cable · Add to Cart ... 04 FT EXT. Spo2 Sensor Masimo 2021 LNC-4-ext · Add to Cart Compare. Quick ...

The NuStep TRS 4000 features a comfortable wheelchair seat. Spinning a full 360 degrees and locks every 45 degrees. This will allow users to access and ...

Cah 200 llcaddress

Nora Lighting NMIOT-13-MPW-AAW-50X-10-B Modern Recessed Light Black.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 107.8% in the fourth quarter. Wellington Management Group LLP now owns 24,348 shares of the company’s stock worth $2,454,000 after buying an additional 12,631 shares during the period. Park Avenue Securities LLC lifted its holdings in Cardinal Health by 16.2% during the first quarter. Park Avenue Securities LLC now owns 6,575 shares of the company’s stock valued at $736,000 after purchasing an additional 918 shares in the last quarter. Ballentine Partners LLC boosted its position in shares of Cardinal Health by 26.0% in the first quarter. Ballentine Partners LLC now owns 3,238 shares of the company’s stock worth $362,000 after purchasing an additional 669 shares during the period. Global Assets Advisory LLC purchased a new stake in shares of Cardinal Health in the first quarter worth $1,881,000. Finally, Gateway Investment Advisers LLC raised its position in shares of Cardinal Health by 53.8% during the 1st quarter. Gateway Investment Advisers LLC now owns 4,791 shares of the company’s stock valued at $536,000 after purchasing an additional 1,675 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. The firm had revenue of $59.87 billion for the quarter, compared to analyst estimates of $58.74 billion. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same period last year, the company earned $1.55 EPS. As a group, sell-side analysts expect that Cardinal Health will post 7.61 earnings per share for the current fiscal year.

Cah 200 llcphone number

If a bag becomes disconnected during your therapy, follow the instructions in 18.6, End Therapy Early Procedure, on page 18-55. Notify your dialysis center.

3400-30 Nitro Flex Fuel Line · Available immediately · Delivery time: 1 - 3 weeks (DE - int. shipments may differ).

In other Cardinal Health news, CEO Jason M. Hollar sold 46,455 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $109.02, for a total transaction of $5,064,524.10. Following the transaction, the chief executive officer now owns 197,636 shares in the company, valued at approximately $21,546,276.72. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now owns 94,529 shares of the company’s stock, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jason M. Hollar sold 46,455 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $109.02, for a total transaction of $5,064,524.10. Following the sale, the chief executive officer now directly owns 197,636 shares of the company’s stock, valued at approximately $21,546,276.72. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 113,963 shares of company stock worth $12,379,980. 0.15% of the stock is owned by corporate insiders.

Cah 200 llccontact number

Who ownscah 200 llc

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Gastric reflux prevention valve Allows for maximum air flow to assist with stomach ulcer prevention Item Id 1006292 MF ID 8888266197 Brand Salem Sump™ ...

Cardinal Health (NYSE:CAH – Get Free Report) had its price target lifted by investment analysts at UBS Group from $125.00 to $134.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price target points to a potential upside of 19.73% from the stock’s previous close.

Cah 200 llcemail address

CAH has been the subject of a number of other reports. Morgan Stanley increased their price target on shares of Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research note on Thursday, August 15th. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday, October 17th. Argus upped their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a research note on Wednesday, September 11th. Robert W. Baird raised their price objective on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Cardinal Health from $115.00 to $119.00 and gave the stock a “hold” rating in a research report on Friday, August 16th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $120.18.

144712 HKDL - Classic Dale ... This pin is part of the 2019 Redemption Series. . It is part of the Disney Classic Series. It has a sculpted flower/leaf vine ...

Mouse anti Human p53 antibody, clone DO-11 recognizes the human Cellular tumor antigen p53, also known as p53 tumor suppressor protein or NY-CO-13. p53 is a ...

Founded in 1967, Ushio America Inc is an industrial light sources manufacturer and distributor headquartered in Cypress, California.

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Shares of Cardinal Health stock opened at $111.92 on Tuesday. Cardinal Health has a 12-month low of $90.19 and a 12-month high of $116.05. The firm has a market cap of $27.26 billion, a PE ratio of 49.74, a price-to-earnings-growth ratio of 1.57 and a beta of 0.60. The company’s fifty day simple moving average is $111.42 and its two-hundred day simple moving average is $103.94.

Buy Thule 765000 Square Bars Reinforced Steel 163cm: Cargo Racks - Amazon.com ✓ FREE DELIVERY possible on eligible purchases.